FDA Releases Guidance for Industry on Designation of New Animal Drugs for Minor Uses or Minor Species

Summary

The Food and Drug Administration (FDA) has released a guidance document to help small businesses comply with new regulations for animal drugs, which aim to make more treatments available for minor animal species and uncommon diseases. The document is related to the Minor Use and Minor Species Animal Health Act of 2004 (MUMS act), a law that was enacted in 2004.